Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cue Biopharma Inc (NQ: CUE )

13.82 USD UNCHANGED
Streaming Delayed Price Updated: 4:02 PM EST, Dec 1, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 13.82
Bid (Size) 13.01 (1)
Ask (Size) 15.00 (10)
Prev. Close 13.82
Today's Range 13.82 - 13.82
52wk Range 9.300 - 31.69
Shares Outstanding 20,130,766
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cue Biopharma to Present at the Piper Sandler 32nd Annual Healthcare Conference
From GlobeNewswire News Releases
Cue Biopharma Extends Research Collaboration for the Development of Immuno-STAT Biologics for the Treatment of Defined Autoimmune Diseases with Merck
From GlobeNewswire News Releases

Performance

YTD
-15.27%
-15.27%
1 Month
+21.98%
+21.98%
3 Month
-14.16%
-14.16%
6 Month
-55.03%
-55.03%
1 Year
+12.36%
+12.36%

More News

Read More
Cue Biopharma Reports Third Quarter 2020 Results and CUE-101 Phase 1 Dose Escalation Trial Updates
From GlobeNewswire News Releases
Cue Biopharma to Present at Upcoming Investor Conferences in November 2020
From GlobeNewswire News Releases
Cue Biopharma to Host Business Update Call and Webcast
From GlobeNewswire News Releases
Cue Biopharma Announces Presentations Highlighting Clinical Progress of CUE-101, Pipeline Progress of CUE-100 Series Immuno-STATs and Immuno-STAT Data for Infectious Disease Applications at the Societ
From GlobeNewswire News Releases
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting
From GlobeNewswire News Releases
Noteworthy Tuesday Option Activity: CUE, FIVE, SSTK
Tags Stocks
From Market News Video
10 Health Care Stocks With Unusual Options Alerts In Today's Session
Tags CVS CUE DHR
From Benzinga
Cue Biopharma Welcomes Tamar Howson to its Board of Directors
From GlobeNewswire News Releases
Analysts Predict 18% Upside For The Holdings of AFSM
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.